FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309712540> ?p ?o ?g. }

• W4309712540 endingPage "104" @default.
• W4309712540 startingPage "95" @default.
• W4309712540 abstract "Cholangiocarcinoma (CCA) are the second most common primary liver tumors and carry a dismal prognosis. Chemosaturation with percutaneous hepatic perfusion (PHP) is a palliative, intra-arterial therapeutic approach that provides a high dose chemotherapy of the liver with reduced systemic exposure. Aim of this retrospective, monocentric study was to analyze PHP as a palliative treatment for unresectable CCA. Toxicity, adverse events and complications were classified using the Common Terminology Criteria for Adverse Events (CTCAE v5.0). Overall response rate (ORR) and disease control rate (DCR) were evaluated according to the Response Evaluation Criteria in Solid Tumors (RECIST1.1). Median overall survival (mOS), median progression-free survival (mPFS) and hepatic mPFS (mhPFS) were computed using Kaplan-Meier estimation. In total 17 patients were treated with 42 PHP between 10/2014 and 09/2020. No significant complications occurred during the interventions. mOS was 27.6 (interquartile range (IQR) 16.5-37) months from first diagnosis and 9.9 (IQR 3.8-21) months from first PHP. mPFS was 4 (IQR 2-7) and mhPFS was 4 (IQR 3-10) months. ORR was 25% and DCR 75%. Significant, but transient hematotoxicity was frequent with grade 3/4 thrombopenia after 50%, leukopenia after 26% and anaemia after 21% of the interventions. An increase of transaminases (AST increase after 21% and ALT increase after 14% of the PHP) developed more often than a deterioration of the liver synthesis capacity. Salvage treatment with PHP has the potential to prolong life in selected patients with unresectable, refractory cholangiocarcinoma. The interventional procedure is safe. Post-interventional toxicity is frequent but manageable." @default.
• W4309712540 created "2022-11-29" @default.
• W4309712540 creator A5004478847 @default.
• W4309712540 creator A5004822329 @default.
• W4309712540 creator A5022604215 @default.
• W4309712540 creator A5050572526 @default.
• W4309712540 creator A5071716340 @default.
• W4309712540 creator A5079270967 @default.
• W4309712540 creator A5079645039 @default.
• W4309712540 creator A5088938129 @default.
• W4309712540 date "2022-11-22" @default.
• W4309712540 modified "2023-09-27" @default.
• W4309712540 title "New perspectives in unresectable cholangiocarcinoma? Evaluation of chemosaturation with percutaneous hepatic perfusion as a palliative treatment option" @default.
• W4309712540 cites W1529734028 @default.
• W4309712540 cites W1931964440 @default.
• W4309712540 cites W1942118595 @default.
• W4309712540 cites W1980044629 @default.
• W4309712540 cites W2011387799 @default.
• W4309712540 cites W2087336559 @default.
• W4309712540 cites W2097829977 @default.
• W4309712540 cites W2112347626 @default.
• W4309712540 cites W2115261608 @default.
• W4309712540 cites W2337387091 @default.
• W4309712540 cites W2373606074 @default.
• W4309712540 cites W2526881395 @default.
• W4309712540 cites W2539716675 @default.
• W4309712540 cites W2587006748 @default.
• W4309712540 cites W2621203737 @default.
• W4309712540 cites W2630584086 @default.
• W4309712540 cites W2776106750 @default.
• W4309712540 cites W2892854372 @default.
• W4309712540 cites W2982321050 @default.
• W4309712540 cites W2982406244 @default.
• W4309712540 cites W3035850430 @default.
• W4309712540 cites W3082097541 @default.
• W4309712540 cites W3087645800 @default.
• W4309712540 cites W3092438256 @default.
• W4309712540 cites W3119400669 @default.
• W4309712540 cites W3127932748 @default.
• W4309712540 cites W3164310383 @default.
• W4309712540 cites W3165133969 @default.
• W4309712540 cites W3177664414 @default.
• W4309712540 cites W4200461424 @default.
• W4309712540 cites W4205519564 @default.
• W4309712540 cites W4239594698 @default.
• W4309712540 doi "https://doi.org/10.1007/s10585-022-10193-4" @default.
• W4309712540 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36417096" @default.
• W4309712540 hasPublicationYear "2022" @default.
• W4309712540 type Work @default.
• W4309712540 citedByCount "0" @default.
• W4309712540 crossrefType "journal-article" @default.
• W4309712540 hasAuthorship W4309712540A5004478847 @default.
• W4309712540 hasAuthorship W4309712540A5004822329 @default.
• W4309712540 hasAuthorship W4309712540A5022604215 @default.
• W4309712540 hasAuthorship W4309712540A5050572526 @default.
• W4309712540 hasAuthorship W4309712540A5071716340 @default.
• W4309712540 hasAuthorship W4309712540A5079270967 @default.
• W4309712540 hasAuthorship W4309712540A5079645039 @default.
• W4309712540 hasAuthorship W4309712540A5088938129 @default.
• W4309712540 hasBestOaLocation W43097125401 @default.
• W4309712540 hasConcept C119060515 @default.
• W4309712540 hasConcept C126322002 @default.
• W4309712540 hasConcept C141071460 @default.
• W4309712540 hasConcept C159110408 @default.
• W4309712540 hasConcept C197934379 @default.
• W4309712540 hasConcept C2776694085 @default.
• W4309712540 hasConcept C2777793932 @default.
• W4309712540 hasConcept C2780140570 @default.
• W4309712540 hasConcept C2780813298 @default.
• W4309712540 hasConcept C2780873365 @default.
• W4309712540 hasConcept C2994186709 @default.
• W4309712540 hasConcept C41260117 @default.
• W4309712540 hasConcept C513090587 @default.
• W4309712540 hasConcept C71924100 @default.
• W4309712540 hasConcept C90924648 @default.
• W4309712540 hasConceptScore W4309712540C119060515 @default.
• W4309712540 hasConceptScore W4309712540C126322002 @default.
• W4309712540 hasConceptScore W4309712540C141071460 @default.
• W4309712540 hasConceptScore W4309712540C159110408 @default.
• W4309712540 hasConceptScore W4309712540C197934379 @default.
• W4309712540 hasConceptScore W4309712540C2776694085 @default.
• W4309712540 hasConceptScore W4309712540C2777793932 @default.
• W4309712540 hasConceptScore W4309712540C2780140570 @default.
• W4309712540 hasConceptScore W4309712540C2780813298 @default.
• W4309712540 hasConceptScore W4309712540C2780873365 @default.
• W4309712540 hasConceptScore W4309712540C2994186709 @default.
• W4309712540 hasConceptScore W4309712540C41260117 @default.
• W4309712540 hasConceptScore W4309712540C513090587 @default.
• W4309712540 hasConceptScore W4309712540C71924100 @default.
• W4309712540 hasConceptScore W4309712540C90924648 @default.
• W4309712540 hasIssue "1" @default.
• W4309712540 hasLocation W43097125401 @default.
• W4309712540 hasLocation W43097125402 @default.
• W4309712540 hasLocation W43097125403 @default.
• W4309712540 hasOpenAccess W4309712540 @default.
• W4309712540 hasPrimaryLocation W43097125401 @default.
• W4309712540 hasRelatedWork W2003938723 @default.
• W4309712540 hasRelatedWork W2047967234 @default.

• next